Advocacy intelligence hub — real-time data for patient organizations
Northwestern University — PHASE2
National Cancer Institute (NCI) — PHASE1
Three Gorges Hospital of Chongqing University
Dana-Farber Cancer Institute
National Cancer Institute (NCI) — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Jia Luo
Dana-Farber - Harvard Cancer Center LAO
Jochen H Lorch, MD, M.D
Northwestern University
📍 CHICAGO, IL
Dawn Pinchasik, MD, M.D
TScan Therapeutics, Inc.
📍 PITTSBURGH, PA
Pasi A Janne, MD, PhD, MD PHD
Dana-Farber Cancer Institute
📍 BOSTON, MA
Judy Chiao, MD
Epigenetix, Inc.
Gianni Bisogno, MD
Azienda Ospedale Università Padova - Italy